author-photo

Kaoru Kondo

Bristol-Myers Squibb

4

Papers

56

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): Interim results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of BMS-708163 in young and elderly Japanese subjects

2010 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)